P/E ratio for SurgePays (SURG)

P/E ratio history for SurgePays from 2018 to 2023

PE ratio at the end of each year

P/E ratio for similar companies or competitors

Company	P/E ratio	P/E ratio differencediff.	Country
STAAR Surgical STAA	55.4	3,009.82%	🇺🇸 USA
Integra LifeSciences IART	20.4	1,042.83%	🇺🇸 USA
Cooper Companies COO	17.2	866.46%	🇺🇸 USA
Stryker Corporation SYK	57.6	3,130.76%	🇺🇸 USA
Johnson & Johnson JNJ	10.3	475.74%	🇺🇸 USA
Novartis NVS	26.4	1,381.04%	🇨🇭 Switzerland
CONMED CNMD	37.4	2,001.59%	🇺🇸 USA

How to read a P/E ratio?

The Price/Earnings ratio measures the relationship between a company's stock price and its earnings per share. A low but positive P/E ratio stands for a company that is generating high earnings compared to its current valuation and might be undervalued. A company with a high negative (near 0) P/E ratio stands for a company that is generating heavy losses compared to its current valuation.

Companies with a P/E ratio over 30 or a negative one are generaly seen as "growth stocks" meaning that investors typically expect the company to grow or to become profitable in the future.
Companies with a positive P/E ratio bellow 10 are generally seen as "value stocks" meaning that the company is already very profitable and unlikely to strong growth in the future.